These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 11008879

  • 1. Anti-apoptotic function of L-(-)deprenyl (Selegiline) and related compounds.
    Naoi M, Maruyama W, Yagi K, Youdim M.
    Neurobiology (Bp); 2000; 8(1):69-80. PubMed ID: 11008879
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. (-)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide.
    Maruyama W, Takahashi T, Naoi M.
    J Neurochem; 1998 Jun; 70(6):2510-5. PubMed ID: 9603216
    [Abstract] [Full Text] [Related]

  • 4. The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W, Takahashi T, Youdim M, Naoi M.
    J Neural Transm (Vienna); 2002 Apr; 109(4):467-81. PubMed ID: 11956966
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotection by (-)-deprenyl and related compounds.
    Maruyama W, Naoi M.
    Mech Ageing Dev; 1999 Nov; 111(2-3):189-200. PubMed ID: 10656536
    [Abstract] [Full Text] [Related]

  • 6. Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl.
    Naoi M, Maruyama W, Takahashi T, Akao Y, Nakagawa Y.
    J Neural Transm Suppl; 2000 Nov; (58):111-21. PubMed ID: 11128601
    [Abstract] [Full Text] [Related]

  • 7. Future of neuroprotection in Parkinson's disease.
    Naoi M, Maruyama W.
    Parkinsonism Relat Disord; 2001 Oct; 8(2):139-45. PubMed ID: 11489679
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
    Maruyama W, Yi H, Takahashi T, Shimazu S, Ohde H, Yoneda F, Iwasa K, Naoi M.
    Life Sci; 2004 May 21; 75(1):107-17. PubMed ID: 15102525
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3.
    Akao Y, Nakagawa Y, Maruyama W, Takahashi T, Naoi M.
    Neurosci Lett; 1999 Jun 04; 267(3):153-6. PubMed ID: 10380999
    [Abstract] [Full Text] [Related]

  • 10. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W, Boulton AA, Davis BA, Dostert P, Naoi M.
    J Neural Transm (Vienna); 2001 Jun 04; 108(1):11-24. PubMed ID: 11261742
    [Abstract] [Full Text] [Related]

  • 11. [Molecular mechanisms of the neuroprotective effect of (-)-deprenyl].
    Pálfi M, Szökó E, Kálmán M.
    Orv Hetil; 2006 Jul 09; 147(27):1251-7. PubMed ID: 16927880
    [Abstract] [Full Text] [Related]

  • 12. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol.
    Maruyama W, Akao Y, Youdim MB, Davis BA, Naoi M.
    J Neurochem; 2001 Aug 09; 78(4):727-35. PubMed ID: 11520893
    [Abstract] [Full Text] [Related]

  • 13. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT, Yu PH.
    Toxicol Appl Pharmacol; 1997 Jan 09; 142(1):186-91. PubMed ID: 9007048
    [Abstract] [Full Text] [Related]

  • 14. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K, Szende B.
    Neurotoxicology; 2004 Jan 09; 25(1-2):233-42. PubMed ID: 14697898
    [Abstract] [Full Text] [Related]

  • 15. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M.
    J Neurochem; 2006 Jan 09; 96(2):541-9. PubMed ID: 16336631
    [Abstract] [Full Text] [Related]

  • 16. N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2.
    Yi H, Maruyama W, Akao Y, Takahashi T, Iwasa K, Youdim MB, Naoi M.
    J Neural Transm (Vienna); 2006 Jan 09; 113(1):21-32. PubMed ID: 15843867
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
    Naoi M, Maruyama W, Akao Y, Zhang J, Parvez H.
    Toxicology; 2000 Nov 16; 153(1-3):123-41. PubMed ID: 11090952
    [Abstract] [Full Text] [Related]

  • 18. Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines.
    Naoi M, Maruyama W, Akao Y, Yi H.
    J Neural Transm (Vienna); 2002 May 16; 109(5-6):607-21. PubMed ID: 12111453
    [Abstract] [Full Text] [Related]

  • 19. The neuroprotective and neuronal rescue effects of (-)-deprenyl.
    Magyar K, Szende B, Lengyel J, Tarczali J, Szatmáry I.
    J Neural Transm Suppl; 1998 May 16; 52():109-23. PubMed ID: 9564614
    [Abstract] [Full Text] [Related]

  • 20. Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
    Sanz E, Romera M, Bellik L, Marco JI, Unzeta M.
    Med Sci Monit; 2004 Dec 16; 10(12):BR477-84. PubMed ID: 15567979
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.